Application of nasal high flow oxygen therapy (hfnc)) to reduce the risk of extubation in patients with tracheotomy

Application of nasal high flow oxygen therapy (hfnc) to reduce the risk of extubation in patients with tracheotomy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048541

Enrollment

Unknown

Registered

2021-07-10

Start date

2021-08-01

Completion date

Unknown

Last updated

2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheotomy

Interventions

Experimental group:Use of high flow oxygen therapy equipment

Control Group:No

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years old; 2. Tracheotomy patients with primary disease control and no need of mechanical ventilation assessed by clinicians; 3. The patient or family members agree and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with dysphagia; 2. Patients with hemodynamic instability; 3. Patients with APACHE II score >= 20; 4. Cough ability <= 2 points; 5. Laryngeal cancer or airway stenosis; 6. Patients with one or more organ failure.

Design outcomes

Primary

Measure	Time frame
Oxygen partial pressure;Partial pressure of carbon dioxide;Sputum volume;Tracheotomy time;	—

Countries

China

Contacts

Public ContactXie Zhenhang

The First Affiliated Hospital of Chongqing Medical University

403029588@qq.com+86 15023920678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026